Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2025
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025
William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 17, 2024
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 18, 2021
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021
William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 12, 2023
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023
William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 17, 2022
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
William J Gradishar, Meena S Moran, Jame Abraham, et al.
Cancer Cell
|
September 12, 2018
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi, Matthew T Chang, Guotai Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial
Sara M Tolaney, Nabihah Tayob, Chau Dang, et al.
NPJ Breast Cancer
|
February 17, 2022
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT
Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2025
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025
William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 17, 2024
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 18, 2021
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021
William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 12, 2023
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023
William J Gradishar, Meena S Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 17, 2022
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
William J Gradishar, Meena S Moran, Jame Abraham, et al.
Cancer Cell
|
September 12, 2018
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi, Matthew T Chang, Guotai Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2021
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial
Sara M Tolaney, Nabihah Tayob, Chau Dang, et al.
NPJ Breast Cancer
|
February 17, 2022
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial
Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT
Paolo Tarantino, Nabihah Tayob, Guillermo Villacampa, et al.
Page
of 8